Jacobi Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.49M Buy
17,194
+87
+0.5% +$8.34K 0.08% 224
2025
Q4
$1.64M Sell
17,107
-526
-3% -$51.1K 0.1% 202
2025
Q3
$1.68M Buy
17,633
+121
+0.7% +$11.1K 0.1% 198
2025
Q2
$1.53M Sell
17,512
-563
-3% -$47.7K 0.1% 199
2025
Q1
$1.62M Sell
18,075
-490
-3% -$43.8K 0.12% 175
2024
Q4
$1.48M Sell
18,565
-343
-2% -$29.7K 0.11% 181
2024
Q3
$1.7M Buy
18,908
+39
+0.2% +$3.28K 0.13% 154
2024
Q2
$1.49M Buy
18,869
+598
+3% +$49K 0.13% 148
2024
Q1
$1.59M Buy
18,271
+100
+0.6% +$8.53K 0.15% 128
2023
Q4
$1.5M Buy
18,171
+1,292
+8% +$98.5K 0.15% 125
2023
Q3
$1.32M Sell
16,879
-1,462
-8% -$122K 0.15% 130
2023
Q2
$1.62M Buy
18,341
+514
+3% +$44.3K 0.18% 110
2023
Q1
$1.44M Buy
17,827
+646
+4% +$52.7K 0.17% 127
2022
Q4
$1.34M Buy
17,181
+3,946
+30% +$320K 0.17% 126
2022
Q3
$1.07M Buy
13,235
+705
+6% +$63.4K 0.15% 141
2022
Q2
$1.13M Buy
12,530
+519
+4% +$52.6K 0.15% 143
2022
Q1
$1.33M Buy
12,011
+1,192
+11% +$126K 0.16% 125
2021
Q4
$1.12M Buy
10,819
+1,288
+14% +$149K 0.13% 147
2021
Q3
$1.2M Buy
9,531
+949
+11% +$123K 0.15% 116
2021
Q2
$1.06M Buy
8,582
+173
+2% +$21.7K 0.14% 128
2021
Q1
$993K Buy
8,409
+22
+0.3% +$2.58K 0.15% 136
2020
Q4
$1.45M Sell
8,387
-343
-4% -$37.8K 0.23% 85
2020
Q3
$939K Sell
8,730
-172
-2% -$17.3K 0.16% 113
2020
Q2
$840K Buy
8,902
+1,207
+16% +$116K 0.16% 115
2020
Q1
$717K Buy
7,695
+99
+1% +$10.5K 0.15% 112
2019
Q4
$887K Buy
7,596
+625
+9% +$68.6K 0.16% 116
2019
Q3
$743K Buy
6,971
+40
+0.6% +$4.17K 0.15% 132
2019
Q2
$678K Buy
6,931
+4,760
+219% +$435K 0.14% 142
2019
Q1
$198K Buy
2,171
+273
+14% +$24.4K 0.05% 229
2018
Q4
$173K Sell
1,898
-93
-5% -$8.69K 0.05% 238
2018
Q3
$196K Buy
1,991
+167
+9% +$15.4K 0.05% 224
2018
Q2
$156K Buy
1,824
+7
+0.4% +$585 0.05% 245
2018
Q1
$141K Buy
1,817
+243
+15% +$20K 0.04% 242
2017
Q4
$135K Buy
1,574
+351
+29% +$28.1K 0.04% 217
2017
Q3
$94K Buy
1,223
+612
+100% +$50.8K 0.03% 251
2017
Q2
$53K Buy
611
+34
+6% +$2.87K 0.02% 296
2017
Q1
$46K Buy
577
+22
+4% +$1.72K 0.02% 258
2016
Q4
$41K Sell
555
-22
-4% -$1.73K 0.03% 242
2016
Q3
$50K Hold
577
0.02% 233
2016
Q2
$50K Buy
+577
New +$46.7K 0.03% 220

Other funds holding MDT

Jacobi Capital Management's MDT Position: Q1 2026 in Review

Jacobi Capital Management increased its Medtronic (MDT) stake by 0.51% in Q1 2026, buying an estimated $8.34K and bringing the position to 17,194 shares worth $1.49M. The position accounts for 0.08% of the portfolio, ranked #224.

Jacobi Capital Management first reported a position in MDT in Q2 2016 and has held it in 40 quarters since. The position peaked at $1.7M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Jacobi Capital Management held 17,194 shares of Medtronic worth $1.49M as of Q1 2026.
  • Jacobi Capital Management bought 87 Medtronic shares in Q1 2026, an estimated $8.34K.
  • Medtronic made up 0.08% of Jacobi Capital Management's portfolio in Q1 2026, its #224 holding.
  • Jacobi Capital Management first reported a position in Medtronic in Q2 2016 and has held it in 40 quarters since.
  • Jacobi Capital Management's Medtronic position peaked at $1.7M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Jacobi Capital Management's 13F filing for Q1 2026, filed 14 May 2026.